Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000109

Chief Legal Officer sold 1,707 shares at $28.36 ($48,411)

  • Chief Legal Officer acquired 5,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burns James William Chief Legal Officer 2023-06-28 Option exercise 10b5-1 +5,750 31,992 D: show line 1 in the form
Burns James William Chief Legal Officer 2023-06-30 Sale 10b5-1 −1,707 $28.36 $48,411 30,285 D: show line 2 in the form
Open-market sales · 1,707 sh · avg $28.36 · $48,411

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Burns James William Chief Legal Officer 2023-06-28 Option exercise · Performance share units 10b5-1 −5,750 5,750 D: show line 3 in the form
Loading xslF345X04/wk-form4_1688155746.xml…